2020 42nd Annual International Conference of the IEEE Engineering in Medicine &Amp; Biology Society (EMBC) 2020
DOI: 10.1109/embc44109.2020.9175358
|View full text |Cite
|
Sign up to set email alerts
|

Deep Learning Based Junctional Zone Quantification using 3D Transvaginal Ultrasound in Assisted Reproduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…However, 3D-TVS is dependent on the quality of the 2D image obtained and may perform better in real time. AI methods involve the use of complex algorithms which facilitate machine learning, and AI has been proposed in the field of gynecological ultrasound for evaluation of the uterus 64 , ovarian cysts 65 , DE 66 and POD obliteration 67 . While the diagnostic accuracy of 3D-TVS and AI in endometriosis has been studied 66,68,69 , these methods are currently limited by a lack of external validation and comparative superiority to 2D-TVS.…”
Section: Ultrasoundmentioning
confidence: 99%
“…However, 3D-TVS is dependent on the quality of the 2D image obtained and may perform better in real time. AI methods involve the use of complex algorithms which facilitate machine learning, and AI has been proposed in the field of gynecological ultrasound for evaluation of the uterus 64 , ovarian cysts 65 , DE 66 and POD obliteration 67 . While the diagnostic accuracy of 3D-TVS and AI in endometriosis has been studied 66,68,69 , these methods are currently limited by a lack of external validation and comparative superiority to 2D-TVS.…”
Section: Ultrasoundmentioning
confidence: 99%
“…In places like the USA, maternal mortality is increasing, despite the contrary trend worldwide. Pregnancy and maternal healthcare generate many different data types (e.g., ultrasound imaging [ 20 ], diagnostic screening, fetal monitoring [ 21 ], genetics) that can be integrated by repro-AI to address maternal health. There is a significant gap in the research on pre-conception, pregnant, and breastfeeding persons and pharmacological safety and efficacy drugs due to their systemic and deliberate exclusion from randomized clinical trials, yet up to 80% of pregnant or lactating women will need to take a pharmacological substance at some point [ 22 ].…”
Section: Introduction   (Trolice)mentioning
confidence: 99%